1. Iagaru A, Quon A, McDougall IR, Gambhir SS. F-18 FDG PET/CT evaluation of osseous and soft tissue sarcomas. Clin Nucl Med. 2006. 31:754–760.
Article
2. Dimitrakopoulou-Strauss A, Strauss LG, Schwarzbach M, et al. Dynamic PET 18F-FDG studies in patients with primary and recurrent soft -tissue sarcomas: impact on diagnosis and correlation with grading. J Nucl Med. 2001. 42:713–720.
3. Coindre JM. Grading of soft tissue sarcomas: review and update. Arch Pathol Lab Med. 2006. 130:1448–1453.
Article
4. Ernest U, Conrad M, Hannah D, et al. Fluorodeoxyglucose positron emission tomography scanning: basic principles and imaging of adult soft-tissue sarcomas. J Bone Joint Surg Am. 2004. 86:98–104.
5. Schöder H, Erdi YE, Chao K, Gonen M, Larson SM, Yeung HW. Clinical implications of different image reconstruction parameters for interpretation of whole-body PET studies in cancer patients. J Nucl Med. 2004. 45:559–566.
6. Aoki J, Watanabe H, Shinozaki T, et al. FDG-PET for preoperative differential diagnosis between benign and malignant soft tissue masses. Skeletal Radiol. 2003. 32:133–138.
Article
7. Lucas JD, O'Doherty MJ, Wong JC, et al. Evaluation of fluorodeoxy glucose positron emission tomography in the management of soft-tissue sarcomas. J Bone Joint Surg Br. 1998. 80:441–447.
8. Hamada K, Tomita Y, Ueda T, et al. Evaluation of delayed 18F-FDG PET in differential diagnosis for malignant soft-tissue tumors. Ann Nucl Med. 2006. 20:671–675.
9. Schwarzbach MH, Dimitrakopoulou-Strauss A, Willeke F, et al. Clinical value of [18-F] fluorodeoxyglucose positron emission tomography imaging in soft tissue sarcomas. Ann Surg. 2000. 231:380–386.
Article
10. Nieweg OE, Pruim J, van Ginkel RJ, et al. Fluorine-18-fluorodeoxyglucose PET imaging of soft-tissue sarcoma. J Nuc Med. 1996. 37:257–261.
11. Salanova V, Markland O, Woth R. Longitudinal follow-up in 145 patients with medically refractory temporal lobe epilepsy treated surgically between 1984 and 1995. Epilepsia. 1999. 40:1417–1423.
Article
12. Smith MA, O'Doherty MJ. Position emission tomography and the orthopaedic surgeon. J Bone Joint Surg Br. 2004. 82:324–325.
13. Feldman F, van Heertum R, Manos C. 18 FDG PET scanning of benign and malignant musculoskeletal lesions. Skeletal Radiol. 2003. 32:201–208.
14. Tateishi U, Yamaguchi U, Seki K, Terauchi T, Arai Y, Kim EE. Bone and soft-tissue sarcoma: preoperative staging with fluorine 18 fluorodeoxyglucose PET/CT and conventional imaging. Radiology. 2007. 245:839–847.
Article